Mobile

The Safety and Tolerability of Intra-abdominal t-PA and DNase on Peritonitis in Peritoneal Dialysis Patients

Mise à jour : Il y a 4 ans
Référence : NCT01478698

Femme et Homme

  • | Pays :
  • Australia
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Hypothesis: Intraperitoneal tPA and DNase is well tolerated at a number of different doses. Different doses of tPA and DNase will have a dose-related effect on inflammatory markers (CRP and intraperitoneal white cell count). Aims: 1. To examine the tolerability of different doses of intraperitoneal tPA and DNase compared to standard treatment. 2. To examine the changes in biochemical and clinical outcomes of PD Peritonitis with the addition of intraperitoneal tPA and DNase to usual therapy.

Critère d'inclusion

  • Peritoneal dialysis ,Peritoneal Dialysis, Continuous Ambulatory

Liens